featured
featured · page 8
- Companies
Curaleaf’s Boris Jordan lifts the lid on EMMAC Life Sciences and Europe plans
The cannabis industry leader made waves by moving into the European market with a huge takeover deal earlier this year
- Cultivation
Swiss Life Sciences Group acquires high-tech Lugano growing facility
The London-based private equity firm is investing in Switzerland’s booming medical cannabis sector
- CBD Market
Tenacious Labs acquires Colorado-based manufacturing operation
The London-based CBD company is continuing to buy up US-based businesses as it looks to expand
- Medical
‘Reform Whitehall to speed up medical cannabis access’ – Conservative MP
The Conservative politician said access needs to be taken out of the Home Office’s remit and put into healthcare structures
- Adult-Use
European reformers ‘must prioritise medical access over recreational’
The MEP behind an EU effort to unlock the cannabis industry across the bloc has outlined his strategy
- CBD Market
Wellness and beauty brand Kloris closes in on equity crowdfunding target
The CBD company is seeking to attract investors via the Seedrs platform
- Pharmaceutical
Oxford Cannabinoid Technologies to list on London Stock Exchange
The medical cannabis company will list on the prestigious market on May 21
- Cultivation
European hemp industry ‘doesn’t need money, it needs reform’
Lorenza Romanese, managing director of the European Industrial Hemp Association, has called for regulatory change
- CBD Market
UK CBD brand Love Hemp makes pair of senior appointments
The company is overhauling its marketing operation with two new hires
- Companies
Avida Global: How a corporate tech consultant became known as ‘Don David’ in Colombia
CEO David Kirby left his corporate European job to run a cannabis operation in South America
- Markets & Stocks
Hellenic Dynamics to become latest cannabis firm to list on LSE
The Greek medical cannabis company will become the first of its kind to list on the capital’s prestigious market
- CBD Market
UK CBD sector set to shrink drastically as regulator culls products
More than half of all CBD applications to remain on UK shelves presently stand no chance of success
